Molecular Classification
Enzyme, Glycoside hydrolase (GH) family 18, Glycoside hydrolase (GH) family 19, Glycoside hydrolase (GH) family 20
Other Names
Chitin-degrading enzyme, Chitinase enzyme, GH18 chitinase, GH19 chitinase, GH20 chitinase, Endochitinase, Exochitinase, Chitotriosidase (specific human chitinase), Chitobiosidase, N-acetylglucosaminidase
Disease Roles
AllergiesAsthmaInfection

Chitinase Overview

Chitinase is an enzyme that catalyzes the hydrolytic cleavage of β-1,4-glycosidic bonds in chitin, a major structural polysaccharide found in the exoskeletons of arthropods (e.g., insects, crustaceans) and fungal cell walls. There are multiple chitinase enzyme families, notably family 18, 19, and 20 glycoside hydrolases, with family 18 found in bacteria, fungi, insects, and mammals, and family 19 mainly in plants[3][5][7][8]. Chitinases are structurally diverse but generally possess a modular architecture including a catalytic domain and, in some forms, a chitin-binding domain[4][5][7]. Their primary function is chitin degradation, involved in nutrient recycling in nature and defense against chitin-containing pathogens in plants and animals[2][5][9]. In humans, active chitinases such as chitotriosidase also play a role in immune responses and have been implicated in diseases such as asthma, allergies, and serve as biomarkers in Gaucher’s disease[3][7]. Drug modulation of chitinase activity is being explored for antifungal and anti-inflammatory therapies, though no approved drugs are currently available for direct chitinase inhibition.

Mechanism of Action

Chitinase inhibitors block chitinase enzymatic activity, thereby reducing the breakdown of chitin; proposed as antifungal, anti-allergic, or anti-asthmatic mechanisms[3]

Biological Functions

Chitin degradation
Immune response
Defense against pathogens
Carbon and nitrogen recycling in ecosystems
Antifungal activity

Disease Associations

Allergies
Asthma
Infection
Inflammation
Gaucher’s disease (biomarker/enzymotherapy role)
Parasitic (helminth) infection

Safety Considerations

  • Off-target effects on endogenous human chitinases, which may play roles in immunity/allergy and pulmonary health
  • Deficiency in chitinase activity in some individuals affecting biomarker interpretation

Interacting Drugs

No widely approved chitinase inhibitors in clinical use; some investigational chitinase inhibitors (e.g., allosamidin in research)
Chitotriosidase is used as a biomarker and may be affected by enzyme-replacement therapies for Gaucher’s disease[3]

Associated Biomarkers

Biomarker
Chitotriosidase (measured in plasma/serum as a biomarker for Gaucher’s disease and some lysosomal storage disorders, as well as a general marker for macrophage activation[3][7])